• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Viral dynamics and immune correlates of COVID-19 disease severity

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Aug 28;ciaa1280.
doi: 10.1093/cid/ciaa1280. Online ahead of print.
Viral dynamics and immune correlates of COVID-19 disease severity


Barnaby E Young[SUP] 1 2 3 [/SUP], Sean W X Ong[SUP] 1 2 [/SUP], Lisa F P Ng[SUP] 4 5 [/SUP], Danielle E Anderson[SUP] 6 [/SUP], Wan Ni Chia[SUP] 6 [/SUP], Po Ying Chia[SUP] 1 2 3 [/SUP], Li Wei Ang[SUP] 1 [/SUP], Tze-Minn Mak[SUP] 1 [/SUP], Shirin Kalimuddin[SUP] 6 7 [/SUP], Louis Yi Ann Chai[SUP] 8 9 [/SUP], Surinder Pada[SUP] 10 [/SUP], Seow Yen Tan[SUP] 11 [/SUP], Louisa Sun[SUP] 12 [/SUP], Purnima Parthasarathy[SUP] 13 [/SUP], Siew-Wai Fong[SUP] 4 5 14 [/SUP], Yi-Hao Chan[SUP] 4 5 [/SUP], Chee Wah Tan[SUP] 5 [/SUP], Bernett Lee[SUP] 5 [/SUP], Olaf R?tzschke[SUP] 5 [/SUP], Ying Ding[SUP] 1 [/SUP], Paul Tambyah[SUP] 8 9 [/SUP], Jenny G H Low[SUP] 6 7 [/SUP], Lin Cui[SUP] 1 [/SUP], Timothy Barkham[SUP] 2 9 [/SUP], Raymond Tzer Pin Lin[SUP] 1 [/SUP], Yee-Sin Leo[SUP] 1 2 3 9 15 [/SUP], Laurent Renia[SUP] 4 5 [/SUP], Lin-Fa Wang[SUP] 6 [/SUP], David Chien Lye[SUP] 1 2 3 9 [/SUP], Singapore 2019 Novel Coronavirus Outbreak Research team



Affiliations

Abstract

Background: Key knowledge gaps remain in the understanding of viral dynamics and immune response of SARS-CoV-2 infection.
Methods: We evaluated these characteristics and established their association with clinical severity in a prospective observational cohort study of 100 patients with PCR-confirmed SARS-CoV-2 infection (mean age 46 years, 56% male, 38% with comorbidities). Respiratory samples (n=74) were collected for viral culture, serum samples for measurement of IgM/IgG levels (n=30), and plasma samples for levels of inflammatory cytokines and chemokines (n=81). Disease severity was correlated with results from viral culture, serologic testing, and immune markers.
Results: 57 (57%) patients developed viral pneumonia, of whom 20 (20%) required supplemental oxygen including 12 (12%) invasive mechanical ventilation. Viral culture from respiratory samples was positive for 19 of 74 patients (26%). No virus was isolated when the PCR cycle threshold (Ct) value was >30 or >14 days after symptom onset. Seroconversion occurred at a median of 12.5 days (IQR 9-18) for IgM and 15.0 days (IQR 12-20) for IgG; 54/62 patients (87.1%) sampled at day 14 or later seroconverted. Severe infections were associated with earlier seroconversion and higher peak IgM and IgG levels. Levels of IP-10, HGF, IL-6, MCP-1, MIP-1α, IL-12p70, IL-18, VEGF-A, PDGF-BB and IL-1RA significantly correlated with disease severity.
Conclusion: We found virus viability was associated with lower PCR Ct value in early illness. A stronger antibody response was associated with disease severity. The overactive proinflammatory immune signatures offers targets for host-directed immunotherapy which should be evaluated in randomised controlled trials.

Keywords: COVID-19; cytokines; immunology; serology; viral culture.
 
Back
Top Bottom